S'abonner

Association of C-reactive protein with markers of prevalent atherosclerotic disease - 03/09/11

Doi : 10.1016/S0002-9149(01)01603-4 
Aaron R Folsom, MD a, , James S Pankow, PhD b, Russell P Tracy, PhD c, Donna K Arnett, PhD a, James M Peacock, MPH a, Yuling Hong, MD d, Luc Djoussé, MD, MPH e, John H Eckfeldt, MD, PhD f

Investigators of the NHLBI Family Heart Study

a Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA 
b Department of Epidemiology, School of Public Health, University of North Carolina, Chapel Hill, North Carolina, USA 
c Departments of Pathology and Biochemistry, University of Vermont, Burlington, Vermont, USA 
d Division of Biostatistics, Washington University, St. Louis, Missouri, USA 
e Section of Preventive Medicine and Epidemiology, Evans Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA 
f Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis, Minnesota, USA 

*Address for reprints: Aaron R. Folsom, MD, Division of Epidemiology, School of Public Health, University of Minnesota, Suite 300, 1300 South 2nd Street, Minneapolis, Minnesota 55454-1015

Abstract

Recent prospective studies have demonstrated that elevated C-reactive protein (CRP) is a marker of increased risk of atherothrombotic clinical events. We examined in a large, cross-sectional family-based study (n = 875 men, 948 women) whether serum CRP was associated with prevalent coronary heart disease (CHD), the ankle/brachial blood pressure index, or carotid intima-media thickness, an indicator of subclinical atherosclerosis as assessed by B-mode ultrasound. CRP was associated with many other cardiovascular risk factors, particularly markers of obesity and insulin resistance, markers of inflammation and acute phase reaction, and hormone replacement therapy. Adjusted for age and family type, there was a weak positive association of CRP with carotid intima-media thickness in both genders and with prevalent CHD in women. However, adjustment for other risk factors completely eliminated the associations. For example, among women, the risk factor-adjusted mean values of intima-media thickness across quartiles of CRP were 0.76, 0.74, 0.75, and 0.76 mm (p >0.5). In men there was a weak inverse association between CRP and ankle/brachial blood pressure index, independent of other risk factors, but no such association in women. Our findings indicate that CRP is not strongly and independently associated with prevalent atherosclerosis. Because CRP has been associated with clinical events, it could be that elevated CRP may be a stronger marker of thrombotic risk than of the degree of atherosclerosis.

Le texte complet de cet article est disponible en PDF.

Plan


 This study was supported in part by cooperative agreement grants U01 HL56563, U01 HL56564, U01 HL56565, U01 HL56566, U01 HL56567, U01 HL56568, U01 HL56569 from the National Heart, Lung, and Blood Institute, Bethesda, Maryland. Manuscript received October 24, 2000; revised manuscript received and accepted February 13, 2001.


© 2001  Excerpta Medica Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 88 - N° 2

P. 112-117 - juillet 2001 Retour au numéro
Article précédent Article précédent
  • Age and the utilization of cardiac catheterization following uncomplicated first acute myocardial infarction treated with thrombolytic therapy (The Second National Registry of Myocardial Infarction [NRMI-2])
  • Frederick A Spencer, Robert J Goldberg, Paul D Frederick, Judith Malmgren, Richard C Becker, Joel M Gore
| Article suivant Article suivant
  • Usefulness of T-axis deviation as an independent risk indicator for incident cardiac events in older men and women free from coronary heart disease (the Cardiovascular Health Study)
  • Pentti M Rautaharju, Jennifer Clark Nelson, Richard A Kronmal, Zhu-Ming Zhang, John Robbins, John S Gottdiener, Curt D Furberg, Teri Manolio, Linda Fried

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.